Charles River Laboratories (CRL)
$179.04-1.27%
Spriggl Score: Moderate— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Industry-leading drug-safety testing lab; cash generation holds despite trough, recovery depends on second-half demand.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Charles River Laboratories
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purp…
- Sector:
- Healthcare
- Industry:
- Diagnostics & Research
- Market Cap:
- $7.7B
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Charles River Laboratories and 1,600+ UK and US stocks.
Start free